StonvexLoading…
StonvexStonvexStonvexCore line items from BLBD's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-28 | Q4 2025 2025-12-27 | Annual 2025 2025-09-27 | Q2 2025 2025-06-28 |
|---|---|---|---|---|
Revenue | $685.72M | $333.08M | $1.48B | $1.07B |
Operating Income | $76.80M | $37.68M | $167.17M | $116.82M |
Net Income | $60.06M | $30.76M | $127.72M | $91.22M |
EPS (Diluted) | $1.84 | $0.94 | $3.88 | $2.76 |
Total Assets | $689.36M | $642.34M | $625.25M | $575.45M |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $275.89M | $241.74M | $229.31M | $173.07M |
Free Cash Flow OCF − CapEx | $71.02M | $31.11M | $153.34M | $92.88M |
Shares Outstanding | 31.65M | 31.68M | 31.88M | 31.48M |